On Wednesday, the U.S. Food and Drug Administration announced the approval of over-the-counter sales for Narcan, an overdose-reversing nasal spray. The FDA green light marks the first naloxone product approved for use without a prescription (only the 4-milligram dose of Narcan has been approved; other formulations, including higher dosages and injectable versions of naloxone, will …
Continue reading “FDA approves over-the-counter sales of overdose-reducing Narcan nasal spray”